PMVP

Pmv Pharmaceuticals INC

-$859.2K

Net Activity

Institutions Holding

69

Popularity Rank

#5257

Avg Weight

0.11%

Total Value

$45.9M

Ownership Trend

69 institutions currently hold PMVP, with 28 net buyers and 28 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Neutral

Based on recent trading activity

Net Selling Institutions

28

Net Buying Institutions

28

Key Holders

View all 69 holding institutions

Quarterly Activity

Recent Activity

+$25.0M

Total Buy Value

$24.1M

Total Sell Value

New buy12
Trim20
Add16
Sold out8

28

Net Buyers

28

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

0

Active 5%+ Holders

Data as of 2026-07-10
Reporting PersonTypeFiling Date% of Class
ArrowMark Colorado Holdings, LLC13G/A2026-07-103.7%

View all Schedule 13D/13G filings

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding PMV PHARMACEUTICALS INC (PMVP)?
Major stakeholders currently include BML Capital Management, LLC ($6.6M), Tang Capital Management LLC ($5.3M), Sio Capital Management, LLC ($3.8M). Based on the latest 13F filings, there are a total of 69 tracked investment funds and institutions maintaining positions in PMVP.
What is the overall institutional sentiment toward PMVP recently?
Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $859.2K, driven by 28 managers accumulating shares while 28 reduced their exposure.
Which institutions have been selling or reducing their PMVP positions?
In the latest period, 20 funds trimmed their holdings, and 8 managers completely exited their positions. The aggregate reported sell value was $24.1M.
Are there any notable investors adding PMVP to their portfolios?
Yes, buying activity remains notable. 12 institutions opened new positions in {ticker}, and 16 existing holders added to their shares. The total reported buy value for the quarter amounted to $25.0M.

Related Stocks